Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

Blood

Volumn 81, Issue 7, 1993, Pages 1709-1719

  Peters, W P ^a   Rosner, G ^a   Ross, M ^a   Vredenburgh, J ^a   Meisenberg, B ^a   Gilbert, C ^a   Kurtzberg, J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; REGRAMOSTIM; UNCLASSIFIED DRUG;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL; HOSPITAL COST; HOSPITALIZATION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LEUKOPENIA; MELANOMA; PRIORITY JOURNAL; RESOURCE ALLOCATION; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0027413697     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v81.7.1709.bloodjournal8171709     Document Type: Article

References (0)